HOLX · HOLOGIC INC
Market Cap
$16.97B
Shares
223.24M
No Price Data
No daily price data is available for this stock yet. Data syncs automatically from Yahoo Finance.
Up next
FQ4-26 quarter ends
~Sep 28, 2026
Est
filed Jan 29, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Limited
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-99% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.67% of float · ▲ +15.5% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
4 holders — near 3-yr low, contrarian setup
Fundamentals
Revenue growth
+2%
Y/Y
Gross margin
52%
contracting
EPS growth
−25%
Y/Y
Free cash flow
$998.3M
Valuation
P/E 31.5
below peers
Buyback
$937.5M
remaining
Balance sheet
$548.4M
net debt
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Feb 1, 2024
quarterly
Quarterly operating expenses
$300M – $310M
annual
Annual effective tax rate
19.75%
Prior guidance
period ended
· from the Earnings Call filed Mar 31, 2024
Total revenue
· Q3 2024
$992.5M – $1.01B
Revenue
· full year 2024
$4B – $4.05B
EPS
· Q3 2024
$0.98 – $1.05
Blood revenue
· full year 2024
$28M
FX tailwind
· full year 2024
$2M
EPS
· full year 2024
$4.02 – $4.12
COVID-related items
· full year 2024
$105M
Annual effective tax rate
· full year fiscal 2024
19.75%
Guided vs delivered
· last 4 settled
Total revenue
Q3 2024
guided $992.5M – $1.01B
$1.01B
Beat +1.1%
Revenue
full year 2024
guided $4B – $4.05B
$4.03B
In line
EPS
Q3 2024
guided $0.98 – $1.05
$0.82
Miss −19.2%
EPS
full year 2024
guided $4.02 – $4.12
$3.32
Miss −18.4%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $330.4M | Q1'26 | — |
GAAP → non-GAAP reconciliationGAAP Non-GAAP net income $235.5M
+$7.9M Interest expense, net
+$60.7M Provision for income taxes
+$26.3M Depreciation expense
= Adjusted EBITDA $330.4M
|
|||
| Adjusted net leverage ratio non-GAAP | 0.3 | Q1'26 | — |
| Adjusted Return on Invested Capital (ROIC) non-GAAP | 13.9% | Q1'26 | — |
| Cash flow from operations | $229.9M | Q1'26 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HOLX
this stock
HOLOGIC INC
|
$16.97B | — | +1.7% | 31.5 | 3.7% |
|
ISRG
Intuitive Surgical Inc
|
$139.37B | -30.3% | +20.5% | 45.3 | 1.9% |
|
BDX
Becton Dickinson & Co
|
$49.96B | — | +8.2% | — | 3.7% |
|
MDLN
Medline Inc.
|
$46.99B | -14.9% | +11.5% | — | 2.6% |
|
ALC
Alcon Inc
|
$35.89B | -5.8% | +10.5% | — | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings